Ovasave

Ovasave is a digital health platform operating in the femtech sector, specifically targeting fertility and women's hormonal health in the Middle East and North Africa (MENA) region. Founded in 2022 by Torkia Mahloul and Majd Abu Zant, the Abu Dhabi-based startup launched in July 2023 with the objective of making fertility care more accessible, convenient, and transparent. The company's inception was inspired by co-founder Torkia Mahloul's personal, complex journey with egg freezing, which highlighted a market need for a more supportive and streamlined process. Mahloul, a tech expert with a background in corporate banking and consumer products, partnered with Majd Abu Zant, a healthcare entrepreneur with two decades of experience in the women's health and fertility space.

The company's core offering is a digital-first platform that provides a suite of services, including at-home hormone testing kits (specifically the AMH test to assess ovarian reserve), virtual consultations with fertility specialists, and personalized supplement protocols. This model allows women to monitor their reproductive health from home, receive results via a secure online portal, and then connect with experts to discuss their options. For clients choosing to proceed with fertility preservation, Ovasave facilitates egg freezing packages through a vetted network of partner clinics, with options for installment payment plans to manage the cost. The business primarily serves working women, typically between their late 20s and late 30s, who are planning for their reproductive future. Ovasave also has a business-to-business component, partnering with corporations like Aldar and Boston Consulting Group to offer fertility care and awareness programs as part of employee wellbeing benefits. The company's revenue is generated through the sale of its at-home testing kits and by charging its partner clinics a fee for the services rendered through its platform.

Since its founding, Ovasave has secured a spot in Abu Dhabi's Hub71 tech ecosystem, gaining access to government and sovereign wealth fund support. In July 2025, the company announced a significant milestone, raising $1.2 million in a pre-seed funding round led by PlusVC, Annex Investments, and 25 Madison. This capital is earmarked for expansion into Saudi Arabia and the wider Gulf Cooperation Council (GCC), scaling its corporate partnerships, and further developing its mobile application to include features like menstrual cycle tracking and AI-driven treatment protocols.

Keywords: femtech, fertility platform, egg freezing, hormonal health, at-home testing, ovarian reserve, reproductive health, women's health, digital health, virtual consultations, fertility preservation, corporate wellness, fertility benefits, AMH test, MENA healthcare, Hub71, fertility support, perimenopause care, menopause support, personalized supplements